Pages

Thursday, 10 October 2013

Cancer Research & Presence Of RIP1 Protein

----------------------------------------------
------------------------------------------------------------------

By Robbie Sutter


There seems to be many different aspects tied into cancer research, which is something that no one can overstate. It's possible that people will have their own ideas as to what the greatest triggers are. What are some of the ways that this condition can raise to the surface and what can be done in order to correct them? These concerns may not be the clearest to think about but a recent story concerning the RIP1 protein has more than been able to grab my attention.

According to an article on BioNews Texas, it's been found that the RIP1 protein could actually inhibit matters related to cancer research. More specifically, it can impact the growth of a number of aggressive tumors associated with the human body, glioblastomas being one of the many examples to consider. This was found out by researchers working within the UT Southwestern Medical Center and I have to believe that this could bring strong results in terms of therapies. It's something for organizations like Voices against Brain Cancer to place focus on.

The RIP1 protein, from what I have picked up on, operates as a cellular switch for tumors in general. More specifically, it is able to maintain to take control of the survival rates of tumor cells, which is done when the protein in question comes into contact with EGFRvIII, which is a receptor. RIP1 and EGFRvIII can come together in order to create NFB as well. What this does is allow the progression of growths within the brain to be regulated; this is pertinent information, to say the least.

It seems like, thanks to this type of information, there could be a solid foundation for finding cures for glioblastomas. For those who do not know, these particular tumors are among the most common - not to mention the most aggressive - within the human body. It's been said that about 30% of tumors found in the brain fall under this category, so it is apparent that they make up for a great percentage. It should be obvious why these particular growths are the focus of many different therapies.

I believe that any kind of information you could think of when it comes to cancer research is going to be immensely helpful in the future. Being able to pick up on smaller details could potentially make all of the difference when it comes to formulating therapies, from the way that I see it. After all, brain cancer is one of the most intricate types of studies out there. It's also one of the greatest endeavors to become involved in and information is very much required.




About the Author:



0 comments:

Post a Comment